Data presented today at the European Society of Cardiology Congress demonstrates the effectiveness of a peptide called FX06 in preventing cardiac damage resulting from treatment following a heart atta...
Studies and Analyses |FIBREX Medical has successfully completed a first dose in man study with its lead product, the anti-inflammatory peptide FX06. FX06 is developed to prevent reperfusion injury, an undesire...
Health and Medicine |Additional Sponsors | |
|
![]() |
![]() |
|
![]() | |
![]() |
|
![]() | |